{"id":"W4400797335","doi":"10.1007/s00277-024-05851-4","title":"Practical considerations in the management of patients treated with bosutinib for chronic myeloid leukemia","year":2024,"lang":"en","type":"review","venue":"Annals of Hematology","topic":"Chronic Myeloid Leukemia Treatments","field":"Medicine","cited_by":7,"is_retracted":false,"has_abstract":true,"ca_institutions":"Princess Margaret Cancer Centre","funders":"Pfizer","keywords":"Bosutinib; Medicine; Tolerability; Dosing; Myeloid leukemia; Adverse effect; Tyrosine-kinase inhibitor; Dasatinib; Oncology; Clinical trial; Internal medicine; Pharmacology; Intensive care medicine; Imatinib; Cancer","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.004110537,0.0004290862,0.0009856311,0.0005520157,0.0008014331,0.002059137,0.0008231355,0.001950429,0.005072234],"category_scores_gemma":[0.01596796,0.0001982844,0.0009195519,0.0004811346,0.0006314447,0.002530289,0.001134264,0.004708232,0.00149654],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0007548296,"about_ca_system_score_gemma":0.002775181,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.001363511,"about_ca_topic_score_gemma":0.00438731,"domain_scores_codex":[0.9965914,0.002085606,0.0005217608,0.0001442033,0.0005350736,0.0001218771],"domain_scores_gemma":[0.9944687,0.00323447,0.0006589426,0.0001274728,0.001057064,0.0004533963],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"not_applicable","study_design_scores_codex":[0.0004303467,0.0001967197,0.002899489,0.00535079,0.0001853451,0.002284033,0.001379547,0.000669185,0.00094821,0.005291554,0.1658766,0.8144882],"study_design_scores_gemma":[0.0003886561,0.0005413294,0.007674328,0.01588851,0.0003909072,0.007176906,0.002369329,0.0008474736,0.0006644048,0.01977942,0.9441463,0.0001324658],"study_design_candidate":"not_applicable","study_design_consensus":null,"genre_codex":"review","genre_gemma":"review","genre_scores_codex":[0.009455301,0.6593029,0.008734317,0.2853371,0.006886869,0.0002328991,0.0003354358,0.0002479175,0.02946728],"genre_scores_gemma":[0.1259186,0.6709663,0.03809283,0.1324236,0.02223517,0.0008219575,0.0007453053,0.000140163,0.008656172],"genre_candidate":"review","genre_consensus":"review","teacher_disagreement_score":0.005072234,"threshold_uncertainty_score":0.02173883,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.1228216331662809,"score_gpt":0.4212472540472785,"score_spread":0.2984256208809976,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}